Owner only: item control page
Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
Kreft, Sophia, Gesierich, Anja, Eigentler, Thomas, Franklin, Cindy, Valpione, Sara, Ugurel, Selma, Utikal, Jochen, Haferkamp, Sebastian, Blank, Christian, Larkin, James
, Garbe, Claus , Schadendorf, Dirk, Lorigan, Paul and Schilling, Bastian
(2019)
Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
European Journal of Cancer 116, pp. 207-215.
Date of publication of this fulltext: 03 Sep 2021 09:59
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Journal of Cancer | ||||
| Publisher: | Elsevier | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 116 | ||||
| Page Range: | pp. 207-215 | ||||
| Date | 2019 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie | ||||
| Identification Number |
| ||||
| Keywords | METASTATIC MELANOMA; COMBINED NIVOLUMAB; BRAF; IPILIMUMAB; DABRAFENIB; SURVIVAL; OUTCOMES; PEMBROLIZUMAB; TRAMETINIB; Melanoma; MAPK; Second-line treatment; PD-1; Ipilimumab | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48516 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric